During the past decade, Hospital Universitario Severo Ochoa conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 16 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 13 clinical trials were completed. i.e. 76.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Severo Ochoa" #1 sponsor was "Spanish Breast Cancer Research Group" with 9 trials, followed by "Fundacion SEIMC-GESIDA" with 5 trials sponsored, "PETHEMA Foundation" with 5 trials sponsored, "Spanish Lung Cancer Group" with 5 trials sponsored and "Fundación GECP" with 5 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Severo Ochoa" #1 collaborator was "Celgene" with 4 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Hospital Universitario 12 de Octubre" with 3 trials as a collaborator. Other collaborators include 52 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Severo Ochoa" are "Breast Cancer" (6 trials), "HIV Infection" (4 trials), "HIV Infections" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials) and "Lung Cancer" (3 trials). Many other conditions were trialed in "Hospital Universitario Severo Ochoa" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Severo Ochoa" are "Drug" (47 trials), "Other" (7 trials), "Device" (4 trials), "Biological" (3 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (5 trials), "Capecitabine" (4 trials), "Trastuzumab" (4 trials), "Placebo" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Severo Ochoa" are 71 trials for "All" genders, 10 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Severo Ochoa". undefined are not yet recruiting, 12 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Hospital Universitario Severo Ochoa, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Severo Ochoa, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 3 trials that are defined as “Not Applicable".